Theravance Biopharma (TBPH) EBT Margin Growth (1y) (2014 - 2026)
Theravance Biopharma (TBPH) EBT Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Theravance Biopharma | 864.56 Mn | 469.90 Mn | - | 5,532.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,532.00 |
| Dec 31, 2025 | 16,144.00 |
| Sep 30, 2025 | 4,514.00 |
| Jun 30, 2025 | 38,623.00 |
| Mar 31, 2025 | -2,015.00 |
| Dec 31, 2024 | -1,911.00 |
| Sep 30, 2024 | -1,127.00 |
| Jun 30, 2024 | -358.00 |
| Mar 31, 2024 | 14,411.00 |
| Dec 31, 2023 | 6,878.00 |
| Sep 30, 2023 | 8,037.00 |
| Jun 30, 2023 | 10,313.00 |
| Mar 31, 2023 | 8,528.00 |
| Dec 31, 2022 | 29,050.00 |
| Sep 30, 2022 | 29,512.00 |
| Jun 30, 2022 | 20,119.00 |
| Mar 31, 2022 | 25,617.00 |
| Dec 31, 2021 | 6,085.00 |
| Sep 30, 2021 | -2,095.00 |
| Jun 30, 2021 | 1,126.00 |